

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of memory T cell differentiation (GO:0043380) | 5.14624675 |
| 2 | behavioral response to nicotine (GO:0035095) | 5.05942675 |
| 3 | negative regulation of multicellular organism growth (GO:0040015) | 4.66059285 |
| 4 | interkinetic nuclear migration (GO:0022027) | 4.34881290 |
| 5 | cellular ketone body metabolic process (GO:0046950) | 4.26701178 |
| 6 | neural tube formation (GO:0001841) | 4.21936943 |
| 7 | behavioral response to ethanol (GO:0048149) | 4.08858915 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 4.05144011 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 4.05144011 |
| 10 | tryptophan catabolic process (GO:0006569) | 4.05144011 |
| 11 | regulation of MHC class I biosynthetic process (GO:0045343) | 4.00532250 |
| 12 | sex differentiation (GO:0007548) | 3.98102069 |
| 13 | kynurenine metabolic process (GO:0070189) | 3.95288936 |
| 14 | indolalkylamine metabolic process (GO:0006586) | 3.81190817 |
| 15 | ketone body metabolic process (GO:1902224) | 3.72899907 |
| 16 | positive regulation of meiosis (GO:0045836) | 3.62601876 |
| 17 | ADP metabolic process (GO:0046031) | 3.60567885 |
| 18 | DNA deamination (GO:0045006) | 3.51898471 |
| 19 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 3.50375733 |
| 20 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.50141606 |
| 21 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.49718043 |
| 22 | synaptic transmission, cholinergic (GO:0007271) | 3.46987858 |
| 23 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.43216956 |
| 24 | rRNA catabolic process (GO:0016075) | 3.42667032 |
| 25 | L-methionine salvage (GO:0071267) | 3.42218661 |
| 26 | L-methionine biosynthetic process (GO:0071265) | 3.42218661 |
| 27 | amino acid salvage (GO:0043102) | 3.42218661 |
| 28 | regulation of female receptivity (GO:0045924) | 3.40146829 |
| 29 | kidney morphogenesis (GO:0060993) | 3.38244043 |
| 30 | positive regulation of meiotic cell cycle (GO:0051446) | 3.36269597 |
| 31 | adaptation of signaling pathway (GO:0023058) | 3.35790820 |
| 32 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.33652391 |
| 33 | detection of light stimulus involved in visual perception (GO:0050908) | 3.33652391 |
| 34 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 3.28593449 |
| 35 | tryptophan metabolic process (GO:0006568) | 3.17685218 |
| 36 | axoneme assembly (GO:0035082) | 3.17020299 |
| 37 | regulation of meiosis I (GO:0060631) | 3.17012772 |
| 38 | fucose catabolic process (GO:0019317) | 3.15793901 |
| 39 | L-fucose metabolic process (GO:0042354) | 3.15793901 |
| 40 | L-fucose catabolic process (GO:0042355) | 3.15793901 |
| 41 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.13805589 |
| 42 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.13805589 |
| 43 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.13805589 |
| 44 | cornea development in camera-type eye (GO:0061303) | 3.13695748 |
| 45 | ubiquinone biosynthetic process (GO:0006744) | 3.12181748 |
| 46 | auditory receptor cell stereocilium organization (GO:0060088) | 3.11304923 |
| 47 | cholesterol catabolic process (GO:0006707) | 3.09264941 |
| 48 | sterol catabolic process (GO:0016127) | 3.09264941 |
| 49 | somite development (GO:0061053) | 3.08400425 |
| 50 | epithelial cilium movement (GO:0003351) | 3.03583372 |
| 51 | phosphatidylethanolamine metabolic process (GO:0046337) | 3.03295622 |
| 52 | protein polyglutamylation (GO:0018095) | 3.02928292 |
| 53 | regulation of establishment of cell polarity (GO:2000114) | 3.02476436 |
| 54 | photoreceptor cell maintenance (GO:0045494) | 3.01773978 |
| 55 | ubiquinone metabolic process (GO:0006743) | 3.01296064 |
| 56 | negative regulation of mast cell activation (GO:0033004) | 2.98186611 |
| 57 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.97492412 |
| 58 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.96018246 |
| 59 | synapsis (GO:0007129) | 2.95735075 |
| 60 | regulation of action potential (GO:0098900) | 2.95700791 |
| 61 | parental behavior (GO:0060746) | 2.93744643 |
| 62 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.89437397 |
| 63 | reciprocal meiotic recombination (GO:0007131) | 2.88785128 |
| 64 | reciprocal DNA recombination (GO:0035825) | 2.88785128 |
| 65 | cilium morphogenesis (GO:0060271) | 2.87827942 |
| 66 | nucleobase catabolic process (GO:0046113) | 2.85258444 |
| 67 | piRNA metabolic process (GO:0034587) | 2.85044558 |
| 68 | somite rostral/caudal axis specification (GO:0032525) | 2.83782439 |
| 69 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.81352709 |
| 70 | aggressive behavior (GO:0002118) | 2.80398635 |
| 71 | proline transport (GO:0015824) | 2.79996262 |
| 72 | limb bud formation (GO:0060174) | 2.79882881 |
| 73 | GPI anchor metabolic process (GO:0006505) | 2.79416828 |
| 74 | female mating behavior (GO:0060180) | 2.79341665 |
| 75 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.77778107 |
| 76 | regulation of mesoderm development (GO:2000380) | 2.77046565 |
| 77 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.76682273 |
| 78 | maternal behavior (GO:0042711) | 2.73291382 |
| 79 | NAD biosynthetic process (GO:0009435) | 2.73125419 |
| 80 | regulation of pigment cell differentiation (GO:0050932) | 2.71653607 |
| 81 | DNA demethylation (GO:0080111) | 2.69623512 |
| 82 | embryonic epithelial tube formation (GO:0001838) | 2.69156083 |
| 83 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.69080350 |
| 84 | gamma-aminobutyric acid transport (GO:0015812) | 2.66451128 |
| 85 | cilium movement (GO:0003341) | 2.65887416 |
| 86 | DNA methylation involved in gamete generation (GO:0043046) | 2.65540521 |
| 87 | protein localization to cilium (GO:0061512) | 2.63971419 |
| 88 | iron-sulfur cluster assembly (GO:0016226) | 2.63455948 |
| 89 | metallo-sulfur cluster assembly (GO:0031163) | 2.63455948 |
| 90 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.62893926 |
| 91 | indole-containing compound metabolic process (GO:0042430) | 2.62822824 |
| 92 | nonmotile primary cilium assembly (GO:0035058) | 2.61017310 |
| 93 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.59914263 |
| 94 | ovulation cycle (GO:0042698) | 2.59258565 |
| 95 | aromatic amino acid family catabolic process (GO:0009074) | 2.58892580 |
| 96 | cell proliferation in forebrain (GO:0021846) | 2.58429626 |
| 97 | head development (GO:0060322) | 2.58138731 |
| 98 | tachykinin receptor signaling pathway (GO:0007217) | 2.53557098 |
| 99 | positive regulation of fatty acid oxidation (GO:0046321) | 2.53011811 |
| 100 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.52259524 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.55178049 |
| 2 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.51138650 |
| 3 | VDR_22108803_ChIP-Seq_LS180_Human | 3.46246584 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.75834253 |
| 5 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.65370580 |
| 6 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.60679058 |
| 7 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.60266567 |
| 8 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.57586490 |
| 9 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.43451289 |
| 10 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.28792625 |
| 11 | ER_23166858_ChIP-Seq_MCF-7_Human | 2.20679603 |
| 12 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.14630329 |
| 13 | FUS_26573619_Chip-Seq_HEK293_Human | 1.97716333 |
| 14 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.96840662 |
| 15 | P300_19829295_ChIP-Seq_ESCs_Human | 1.96503325 |
| 16 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.91900348 |
| 17 | EWS_26573619_Chip-Seq_HEK293_Human | 1.86609484 |
| 18 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.86440428 |
| 19 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.73843621 |
| 20 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.72340585 |
| 21 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.72196642 |
| 22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.72122915 |
| 23 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.71780775 |
| 24 | STAT3_23295773_ChIP-Seq_U87_Human | 1.70351688 |
| 25 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.68231202 |
| 26 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.66861987 |
| 27 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.66542608 |
| 28 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.66539614 |
| 29 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.64095192 |
| 30 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.63073182 |
| 31 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.62606677 |
| 32 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.60610498 |
| 33 | AR_25329375_ChIP-Seq_VCAP_Human | 1.59367325 |
| 34 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.56008900 |
| 35 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.52518347 |
| 36 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.52381603 |
| 37 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.52381603 |
| 38 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.49722651 |
| 39 | TCF4_23295773_ChIP-Seq_U87_Human | 1.49339933 |
| 40 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.49036550 |
| 41 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.47204606 |
| 42 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.46566461 |
| 43 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.44017341 |
| 44 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.43046046 |
| 45 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.41927579 |
| 46 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.38998761 |
| 47 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.37195507 |
| 48 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.35976109 |
| 49 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.34653291 |
| 50 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.32733279 |
| 51 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.30868050 |
| 52 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.29514347 |
| 53 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.29136006 |
| 54 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.27287779 |
| 55 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24780468 |
| 56 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.24780468 |
| 57 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.23940982 |
| 58 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.23721320 |
| 59 | KDM2B_26808549_Chip-Seq_REH_Human | 1.22902285 |
| 60 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.22187691 |
| 61 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.21262650 |
| 62 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.21262650 |
| 63 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.19584885 |
| 64 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.19368429 |
| 65 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.17312698 |
| 66 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.16584970 |
| 67 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.16470910 |
| 68 | NCOR_22424771_ChIP-Seq_293T_Human | 1.15688046 |
| 69 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.14909886 |
| 70 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.14702903 |
| 71 | AR_20517297_ChIP-Seq_VCAP_Human | 1.13861889 |
| 72 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.12898114 |
| 73 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.12898114 |
| 74 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12878042 |
| 75 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.11885843 |
| 76 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.11280075 |
| 77 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.10853447 |
| 78 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.10527075 |
| 79 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.10520773 |
| 80 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.10242434 |
| 81 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.09722880 |
| 82 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.09259998 |
| 83 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.07995689 |
| 84 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07277251 |
| 85 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.07129600 |
| 86 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.07104048 |
| 87 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.06706551 |
| 88 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.05027144 |
| 89 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.03569094 |
| 90 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02442106 |
| 91 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.02120585 |
| 92 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.01918493 |
| 93 | JUN_21703547_ChIP-Seq_K562_Human | 1.01339807 |
| 94 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00878609 |
| 95 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.00847986 |
| 96 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.00678364 |
| 97 | RXR_22108803_ChIP-Seq_LS180_Human | 0.99859974 |
| 98 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.99645372 |
| 99 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.98333008 |
| 100 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.97746511 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006292_abnormal_olfactory_placode | 3.58309928 |
| 2 | MP0002653_abnormal_ependyma_morphology | 2.97337044 |
| 3 | MP0005646_abnormal_pituitary_gland | 2.88056243 |
| 4 | MP0003646_muscle_fatigue | 2.79592025 |
| 5 | MP0001968_abnormal_touch/_nociception | 2.75190719 |
| 6 | MP0003011_delayed_dark_adaptation | 2.63360113 |
| 7 | MP0001501_abnormal_sleep_pattern | 2.46141592 |
| 8 | MP0002234_abnormal_pharynx_morphology | 2.38892420 |
| 9 | MP0005551_abnormal_eye_electrophysiolog | 2.34998479 |
| 10 | MP0002102_abnormal_ear_morphology | 2.33851064 |
| 11 | MP0002876_abnormal_thyroid_physiology | 2.28004324 |
| 12 | MP0003880_abnormal_central_pattern | 2.25396258 |
| 13 | MP0000569_abnormal_digit_pigmentation | 2.11937396 |
| 14 | MP0001986_abnormal_taste_sensitivity | 2.08658315 |
| 15 | MP0003252_abnormal_bile_duct | 2.06265017 |
| 16 | MP0005253_abnormal_eye_physiology | 2.05745679 |
| 17 | MP0006072_abnormal_retinal_apoptosis | 2.05457605 |
| 18 | MP0003787_abnormal_imprinting | 2.04192817 |
| 19 | MP0002736_abnormal_nociception_after | 2.02434603 |
| 20 | MP0000427_abnormal_hair_cycle | 1.97687892 |
| 21 | MP0004885_abnormal_endolymph | 1.96137925 |
| 22 | MP0008877_abnormal_DNA_methylation | 1.90456880 |
| 23 | MP0002837_dystrophic_cardiac_calcinosis | 1.89198043 |
| 24 | MP0009745_abnormal_behavioral_response | 1.86836670 |
| 25 | MP0005084_abnormal_gallbladder_morpholo | 1.83754078 |
| 26 | MP0010386_abnormal_urinary_bladder | 1.80547174 |
| 27 | MP0002282_abnormal_trachea_morphology | 1.80497824 |
| 28 | MP0000631_abnormal_neuroendocrine_gland | 1.80307508 |
| 29 | MP0003195_calcinosis | 1.74666972 |
| 30 | MP0002928_abnormal_bile_duct | 1.66756479 |
| 31 | MP0005174_abnormal_tail_pigmentation | 1.60081698 |
| 32 | MP0005645_abnormal_hypothalamus_physiol | 1.57769239 |
| 33 | MP0000383_abnormal_hair_follicle | 1.49799109 |
| 34 | MP0001764_abnormal_homeostasis | 1.47542090 |
| 35 | MP0002163_abnormal_gland_morphology | 1.44135629 |
| 36 | MP0004133_heterotaxia | 1.41845186 |
| 37 | MP0005085_abnormal_gallbladder_physiolo | 1.40370610 |
| 38 | MP0004043_abnormal_pH_regulation | 1.38464521 |
| 39 | MP0010368_abnormal_lymphatic_system | 1.33964512 |
| 40 | MP0002272_abnormal_nervous_system | 1.32626452 |
| 41 | MP0005167_abnormal_blood-brain_barrier | 1.31952991 |
| 42 | MP0001188_hyperpigmentation | 1.30891773 |
| 43 | MP0009764_decreased_sensitivity_to | 1.29514655 |
| 44 | MP0001486_abnormal_startle_reflex | 1.23776154 |
| 45 | MP0008872_abnormal_physiological_respon | 1.22300551 |
| 46 | MP0004145_abnormal_muscle_electrophysio | 1.20900963 |
| 47 | MP0009697_abnormal_copulation | 1.18156011 |
| 48 | MP0002572_abnormal_emotion/affect_behav | 1.15830189 |
| 49 | MP0006276_abnormal_autonomic_nervous | 1.11853413 |
| 50 | MP0000026_abnormal_inner_ear | 1.11243291 |
| 51 | MP0001970_abnormal_pain_threshold | 1.11214918 |
| 52 | MP0005647_abnormal_sex_gland | 1.08564478 |
| 53 | MP0002254_reproductive_system_inflammat | 1.06521237 |
| 54 | MP0000049_abnormal_middle_ear | 1.06470118 |
| 55 | MP0001984_abnormal_olfaction | 1.06436839 |
| 56 | MP0003119_abnormal_digestive_system | 1.06189692 |
| 57 | MP0003718_maternal_effect | 1.05648871 |
| 58 | MP0002733_abnormal_thermal_nociception | 1.05235940 |
| 59 | MP0004130_abnormal_muscle_cell | 1.03208099 |
| 60 | MP0008875_abnormal_xenobiotic_pharmacok | 1.02760557 |
| 61 | MP0003635_abnormal_synaptic_transmissio | 0.98995427 |
| 62 | MP0008789_abnormal_olfactory_epithelium | 0.98553770 |
| 63 | MP0002160_abnormal_reproductive_system | 0.97945109 |
| 64 | MP0000681_abnormal_thyroid_gland | 0.96747295 |
| 65 | MP0002064_seizures | 0.96091917 |
| 66 | MP0001963_abnormal_hearing_physiology | 0.94407255 |
| 67 | MP0005389_reproductive_system_phenotype | 0.91929165 |
| 68 | MP0000230_abnormal_systemic_arterial | 0.91879703 |
| 69 | MP0002138_abnormal_hepatobiliary_system | 0.90154419 |
| 70 | MP0002938_white_spotting | 0.89908643 |
| 71 | MP0004147_increased_porphyrin_level | 0.89137520 |
| 72 | MP0005195_abnormal_posterior_eye | 0.88782508 |
| 73 | MP0001485_abnormal_pinna_reflex | 0.88346266 |
| 74 | MP0009046_muscle_twitch | 0.88307545 |
| 75 | MP0005310_abnormal_salivary_gland | 0.86757160 |
| 76 | MP0003137_abnormal_impulse_conducting | 0.85684693 |
| 77 | MP0000372_irregular_coat_pigmentation | 0.85677570 |
| 78 | MP0005379_endocrine/exocrine_gland_phen | 0.85130106 |
| 79 | MP0002751_abnormal_autonomic_nervous | 0.84569156 |
| 80 | MP0008058_abnormal_DNA_repair | 0.84300988 |
| 81 | MP0002752_abnormal_somatic_nervous | 0.82407736 |
| 82 | MP0006054_spinal_hemorrhage | 0.81645912 |
| 83 | MP0003938_abnormal_ear_development | 0.81173861 |
| 84 | MP0002063_abnormal_learning/memory/cond | 0.80848512 |
| 85 | MP0003698_abnormal_male_reproductive | 0.80841019 |
| 86 | MP0002735_abnormal_chemical_nociception | 0.80759933 |
| 87 | MP0000470_abnormal_stomach_morphology | 0.80331624 |
| 88 | MP0002557_abnormal_social/conspecific_i | 0.79638172 |
| 89 | MP0000015_abnormal_ear_pigmentation | 0.75968507 |
| 90 | MP0003315_abnormal_perineum_morphology | 0.75248805 |
| 91 | MP0002009_preneoplasia | 0.75208447 |
| 92 | MP0003283_abnormal_digestive_organ | 0.74989579 |
| 93 | MP0005410_abnormal_fertilization | 0.74452922 |
| 94 | MP0002734_abnormal_mechanical_nocicepti | 0.74170127 |
| 95 | MP0001119_abnormal_female_reproductive | 0.72865280 |
| 96 | MP0005423_abnormal_somatic_nervous | 0.71099332 |
| 97 | MP0004215_abnormal_myocardial_fiber | 0.70812975 |
| 98 | MP0002095_abnormal_skin_pigmentation | 0.69879828 |
| 99 | MP0009379_abnormal_foot_pigmentation | 0.68585752 |
| 100 | MP0004134_abnormal_chest_morphology | 0.67254770 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Genetic anticipation (HP:0003743) | 4.86407200 |
| 2 | Pancreatic cysts (HP:0001737) | 4.37736463 |
| 3 | Progressive cerebellar ataxia (HP:0002073) | 4.15226755 |
| 4 | True hermaphroditism (HP:0010459) | 4.01155877 |
| 5 | Pancreatic fibrosis (HP:0100732) | 4.00896089 |
| 6 | Nephronophthisis (HP:0000090) | 3.63504607 |
| 7 | Pendular nystagmus (HP:0012043) | 3.59805557 |
| 8 | Type II lissencephaly (HP:0007260) | 3.39012497 |
| 9 | Hyperglycinuria (HP:0003108) | 3.33020612 |
| 10 | Congenital stationary night blindness (HP:0007642) | 3.25174928 |
| 11 | Molar tooth sign on MRI (HP:0002419) | 3.23488845 |
| 12 | Abnormality of midbrain morphology (HP:0002418) | 3.23488845 |
| 13 | Gaze-evoked nystagmus (HP:0000640) | 3.22556384 |
| 14 | Keratoconus (HP:0000563) | 3.20730633 |
| 15 | Increased corneal curvature (HP:0100692) | 3.20730633 |
| 16 | Decreased central vision (HP:0007663) | 3.14364086 |
| 17 | Bilateral microphthalmos (HP:0007633) | 3.09471020 |
| 18 | Cystic liver disease (HP:0006706) | 3.01769757 |
| 19 | Chorioretinal atrophy (HP:0000533) | 3.00912787 |
| 20 | Abnormality of the renal medulla (HP:0100957) | 3.00702178 |
| 21 | Prostate neoplasm (HP:0100787) | 2.98326092 |
| 22 | Hyperventilation (HP:0002883) | 2.79399474 |
| 23 | Abnormal biliary tract physiology (HP:0012439) | 2.79273690 |
| 24 | Bile duct proliferation (HP:0001408) | 2.79273690 |
| 25 | Abnormality of macular pigmentation (HP:0008002) | 2.79180021 |
| 26 | Abolished electroretinogram (ERG) (HP:0000550) | 2.73074488 |
| 27 | Medial flaring of the eyebrow (HP:0010747) | 2.70335784 |
| 28 | Action tremor (HP:0002345) | 2.67030154 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.64825813 |
| 30 | Abnormality of glycine metabolism (HP:0010895) | 2.64825813 |
| 31 | Hypoplasia of the fovea (HP:0007750) | 2.60400074 |
| 32 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.60400074 |
| 33 | Hypochromic microcytic anemia (HP:0004840) | 2.60325786 |
| 34 | Attenuation of retinal blood vessels (HP:0007843) | 2.58839720 |
| 35 | Febrile seizures (HP:0002373) | 2.58441099 |
| 36 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.56966829 |
| 37 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.55790178 |
| 38 | Abnormality of alanine metabolism (HP:0010916) | 2.55790178 |
| 39 | Hyperalaninemia (HP:0003348) | 2.55790178 |
| 40 | Stomach cancer (HP:0012126) | 2.51499712 |
| 41 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.46173407 |
| 42 | Sclerocornea (HP:0000647) | 2.43840633 |
| 43 | Hypoplasia of the uterus (HP:0000013) | 2.42076022 |
| 44 | Abnormality of the renal cortex (HP:0011035) | 2.42071975 |
| 45 | Cerebellar dysplasia (HP:0007033) | 2.41899366 |
| 46 | Tubular atrophy (HP:0000092) | 2.32206350 |
| 47 | Thyroid-stimulating hormone excess (HP:0002925) | 2.31746284 |
| 48 | Male pseudohermaphroditism (HP:0000037) | 2.28735543 |
| 49 | Gait imbalance (HP:0002141) | 2.26399751 |
| 50 | Congenital, generalized hypertrichosis (HP:0004540) | 2.24170979 |
| 51 | Congenital primary aphakia (HP:0007707) | 2.21850843 |
| 52 | Absent speech (HP:0001344) | 2.15526629 |
| 53 | Chronic hepatic failure (HP:0100626) | 2.13575685 |
| 54 | Choroideremia (HP:0001139) | 2.13106019 |
| 55 | Furrowed tongue (HP:0000221) | 2.10784121 |
| 56 | Progressive inability to walk (HP:0002505) | 2.10569108 |
| 57 | Protruding tongue (HP:0010808) | 2.10405114 |
| 58 | Nephrogenic diabetes insipidus (HP:0009806) | 2.07365717 |
| 59 | Abnormality of the fovea (HP:0000493) | 2.04787606 |
| 60 | Genital tract atresia (HP:0001827) | 2.04016973 |
| 61 | Severe visual impairment (HP:0001141) | 2.03574020 |
| 62 | Ketoacidosis (HP:0001993) | 2.02850357 |
| 63 | Absent/shortened dynein arms (HP:0200106) | 2.02367137 |
| 64 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.02367137 |
| 65 | Focal seizures (HP:0007359) | 2.02209088 |
| 66 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.01763009 |
| 67 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.99897598 |
| 68 | Decreased circulating renin level (HP:0003351) | 1.99334395 |
| 69 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.99113605 |
| 70 | Vaginal atresia (HP:0000148) | 1.96493520 |
| 71 | Partial agenesis of the corpus callosum (HP:0001338) | 1.95911379 |
| 72 | Congenital hepatic fibrosis (HP:0002612) | 1.95554631 |
| 73 | Pachygyria (HP:0001302) | 1.94779792 |
| 74 | Absence seizures (HP:0002121) | 1.92986822 |
| 75 | Abnormal finger flexion creases (HP:0006143) | 1.91693736 |
| 76 | Macular degeneration (HP:0000608) | 1.91636972 |
| 77 | Concave nail (HP:0001598) | 1.90062695 |
| 78 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.89801907 |
| 79 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.89718355 |
| 80 | Retinitis pigmentosa (HP:0000510) | 1.89317478 |
| 81 | Anencephaly (HP:0002323) | 1.88536824 |
| 82 | Inability to walk (HP:0002540) | 1.88280315 |
| 83 | Hydroxyprolinuria (HP:0003080) | 1.86857594 |
| 84 | Abnormality of proline metabolism (HP:0010907) | 1.86857594 |
| 85 | Clumsiness (HP:0002312) | 1.86378370 |
| 86 | Lissencephaly (HP:0001339) | 1.86170913 |
| 87 | Abnormality of the hepatic vasculature (HP:0006707) | 1.85889782 |
| 88 | Dialeptic seizures (HP:0011146) | 1.85202373 |
| 89 | Abnormal drinking behavior (HP:0030082) | 1.84889145 |
| 90 | Polydipsia (HP:0001959) | 1.84889145 |
| 91 | Ketosis (HP:0001946) | 1.81524144 |
| 92 | Widely spaced teeth (HP:0000687) | 1.81302534 |
| 93 | Abnormality of the nasal septum (HP:0000419) | 1.80638810 |
| 94 | Abnormality of the pubic bones (HP:0003172) | 1.78867400 |
| 95 | Hypochromic anemia (HP:0001931) | 1.77649181 |
| 96 | Volvulus (HP:0002580) | 1.77527906 |
| 97 | Postaxial foot polydactyly (HP:0001830) | 1.76504377 |
| 98 | Morphological abnormality of the middle ear (HP:0008609) | 1.76297910 |
| 99 | Astigmatism (HP:0000483) | 1.74872136 |
| 100 | Dysdiadochokinesis (HP:0002075) | 1.73754827 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.24389656 |
| 2 | CDK19 | 4.94630871 |
| 3 | BMPR1B | 3.81613744 |
| 4 | TIE1 | 3.16621820 |
| 5 | INSRR | 3.15108090 |
| 6 | OXSR1 | 2.66895753 |
| 7 | ADRBK2 | 2.60124119 |
| 8 | PINK1 | 2.45746238 |
| 9 | GRK1 | 2.36195012 |
| 10 | ACVR1B | 2.20537804 |
| 11 | ZAK | 2.20072152 |
| 12 | STK38L | 2.18490816 |
| 13 | TAOK3 | 2.08857109 |
| 14 | MAPK13 | 1.92361908 |
| 15 | BCR | 1.86640379 |
| 16 | MAP4K2 | 1.79397970 |
| 17 | NUAK1 | 1.58536785 |
| 18 | TNK2 | 1.56655989 |
| 19 | EPHA4 | 1.56600571 |
| 20 | MAP3K4 | 1.51034527 |
| 21 | LATS1 | 1.46518626 |
| 22 | WNK3 | 1.40489174 |
| 23 | TNIK | 1.39421432 |
| 24 | PNCK | 1.34805265 |
| 25 | KIT | 1.26780885 |
| 26 | STK3 | 1.24776054 |
| 27 | TEC | 1.23484532 |
| 28 | WNK4 | 1.23227938 |
| 29 | IRAK1 | 1.15581476 |
| 30 | GRK7 | 1.11432827 |
| 31 | MAP3K7 | 1.08302232 |
| 32 | VRK1 | 1.04137637 |
| 33 | DAPK2 | 0.99364495 |
| 34 | TRIM28 | 0.99227534 |
| 35 | TLK1 | 0.98816074 |
| 36 | MAP2K7 | 0.98267668 |
| 37 | ADRBK1 | 0.95469287 |
| 38 | PTK2B | 0.94222603 |
| 39 | STK11 | 0.92955403 |
| 40 | MUSK | 0.92544357 |
| 41 | TXK | 0.89543428 |
| 42 | CASK | 0.84084267 |
| 43 | BMPR2 | 0.80396694 |
| 44 | PRKCE | 0.79372713 |
| 45 | TGFBR2 | 0.77243480 |
| 46 | MARK1 | 0.71955034 |
| 47 | NTRK3 | 0.69730867 |
| 48 | MAPK15 | 0.67494151 |
| 49 | IKBKB | 0.63728927 |
| 50 | DYRK2 | 0.62382357 |
| 51 | PRKCG | 0.60225886 |
| 52 | PDK2 | 0.59303196 |
| 53 | ERBB2 | 0.57923304 |
| 54 | TAF1 | 0.57698788 |
| 55 | MAPKAPK5 | 0.55530578 |
| 56 | PLK2 | 0.54103937 |
| 57 | GRK5 | 0.52505599 |
| 58 | PIK3CA | 0.50958017 |
| 59 | CDK3 | 0.49325991 |
| 60 | MATK | 0.47794992 |
| 61 | SIK2 | 0.47511872 |
| 62 | MARK3 | 0.47162304 |
| 63 | ABL1 | 0.47053234 |
| 64 | VRK2 | 0.46806105 |
| 65 | PBK | 0.45897444 |
| 66 | TGFBR1 | 0.45894375 |
| 67 | ERBB3 | 0.44182046 |
| 68 | CSNK1A1 | 0.43463706 |
| 69 | MAP3K13 | 0.42253133 |
| 70 | SGK2 | 0.40926020 |
| 71 | MKNK2 | 0.40836520 |
| 72 | RPS6KA4 | 0.38287345 |
| 73 | PRKACA | 0.37979686 |
| 74 | IGF1R | 0.37068142 |
| 75 | RPS6KA6 | 0.36650123 |
| 76 | EIF2AK2 | 0.35929289 |
| 77 | CSNK1G2 | 0.34872617 |
| 78 | STK39 | 0.34775554 |
| 79 | DYRK3 | 0.33536961 |
| 80 | CHUK | 0.33331729 |
| 81 | PRKCQ | 0.32597467 |
| 82 | ATR | 0.31932972 |
| 83 | CAMK2A | 0.31583679 |
| 84 | FER | 0.31395393 |
| 85 | PRKAA2 | 0.31239798 |
| 86 | NEK2 | 0.30333010 |
| 87 | CSNK1G3 | 0.28941714 |
| 88 | MKNK1 | 0.28931999 |
| 89 | SYK | 0.28916876 |
| 90 | JAK3 | 0.28707770 |
| 91 | MAPKAPK3 | 0.28603740 |
| 92 | PRKG1 | 0.27577976 |
| 93 | RPS6KA5 | 0.27082831 |
| 94 | OBSCN | 0.26835857 |
| 95 | PRKCA | 0.26801513 |
| 96 | FLT3 | 0.26769004 |
| 97 | PHKG2 | 0.26451349 |
| 98 | PHKG1 | 0.26451349 |
| 99 | CSNK1A1L | 0.25537281 |
| 100 | HIPK2 | 0.25059642 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 3.23888739 |
| 2 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.22633888 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.17148475 |
| 4 | Phototransduction_Homo sapiens_hsa04744 | 2.49925989 |
| 5 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.41511614 |
| 6 | Nicotine addiction_Homo sapiens_hsa05033 | 2.32577538 |
| 7 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.29780592 |
| 8 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.18888516 |
| 9 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.14548004 |
| 10 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.07150367 |
| 11 | Olfactory transduction_Homo sapiens_hsa04740 | 2.04503436 |
| 12 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.90704102 |
| 13 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.86292631 |
| 14 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.84747304 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 1.82045386 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.80187754 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.79008953 |
| 18 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.77647148 |
| 19 | Morphine addiction_Homo sapiens_hsa05032 | 1.59334334 |
| 20 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.52807603 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.46972622 |
| 22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.44780575 |
| 23 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.43065735 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.43025347 |
| 25 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.41109919 |
| 26 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.36954083 |
| 27 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.32818094 |
| 28 | Basal transcription factors_Homo sapiens_hsa03022 | 1.27187473 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.26581891 |
| 30 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.25081697 |
| 31 | Asthma_Homo sapiens_hsa05310 | 1.19330476 |
| 32 | Salivary secretion_Homo sapiens_hsa04970 | 1.19298509 |
| 33 | Histidine metabolism_Homo sapiens_hsa00340 | 1.19232543 |
| 34 | Insulin secretion_Homo sapiens_hsa04911 | 1.19130445 |
| 35 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.18082595 |
| 36 | Circadian entrainment_Homo sapiens_hsa04713 | 1.16708290 |
| 37 | Homologous recombination_Homo sapiens_hsa03440 | 1.15242545 |
| 38 | ABC transporters_Homo sapiens_hsa02010 | 1.14303326 |
| 39 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.13078000 |
| 40 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.12451806 |
| 41 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.12209723 |
| 42 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.10357511 |
| 43 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.08207418 |
| 44 | GABAergic synapse_Homo sapiens_hsa04727 | 1.05937182 |
| 45 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.02753582 |
| 46 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.02189136 |
| 47 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.00628632 |
| 48 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.98233771 |
| 49 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.97624602 |
| 50 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.91166631 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.86026458 |
| 52 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.84728112 |
| 53 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.84479372 |
| 54 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.84271522 |
| 55 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.83795622 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.81301645 |
| 57 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.80872979 |
| 58 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.80455824 |
| 59 | Peroxisome_Homo sapiens_hsa04146 | 0.79284072 |
| 60 | RNA polymerase_Homo sapiens_hsa03020 | 0.77877994 |
| 61 | Long-term depression_Homo sapiens_hsa04730 | 0.77658248 |
| 62 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.76748384 |
| 63 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.76302351 |
| 64 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.76052419 |
| 65 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.75633020 |
| 66 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.74082587 |
| 67 | Allograft rejection_Homo sapiens_hsa05330 | 0.73993484 |
| 68 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.72690478 |
| 69 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.70519787 |
| 70 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.69922825 |
| 71 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.67095698 |
| 72 | Cocaine addiction_Homo sapiens_hsa05030 | 0.64615552 |
| 73 | RNA degradation_Homo sapiens_hsa03018 | 0.62971386 |
| 74 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.61514060 |
| 75 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.60352456 |
| 76 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.59020846 |
| 77 | Renin secretion_Homo sapiens_hsa04924 | 0.58527915 |
| 78 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.56453130 |
| 79 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.54700653 |
| 80 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51432911 |
| 81 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.48043852 |
| 82 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.46877649 |
| 83 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.46600704 |
| 84 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.44753705 |
| 85 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.44635366 |
| 86 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.43720059 |
| 87 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.42751042 |
| 88 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.40760971 |
| 89 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.39184506 |
| 90 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.38038679 |
| 91 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.37743556 |
| 92 | Circadian rhythm_Homo sapiens_hsa04710 | 0.37028121 |
| 93 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36616270 |
| 94 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.35338707 |
| 95 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.35163295 |
| 96 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.32438569 |
| 97 | Purine metabolism_Homo sapiens_hsa00230 | 0.32024308 |
| 98 | Mineral absorption_Homo sapiens_hsa04978 | 0.31526180 |
| 99 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.30460948 |
| 100 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.30002004 |

